ORIM Weekly W28 2022

EDITORIAL

Probiotics have captured public imagination, but the science is more nuanced than 'good bacteria.' This week, we dissect which probiotic strains have genuine clinical evidence, what conditions they address, and why strain specificity matters enormously.

Strain-Specific Probiotic Effects

Not all probiotics are equal. A 2021 position paper in Nature Reviews Gastroenterology emphasized that health effects are strain-specific and cannot be extrapolated between species or even between strains of the same species. Lactobacillus rhamnosus GG reduces antibiotic-associated diarrhea, while L. rhamnosus HN001 supports immune function in pregnancy. The strain designation (letters/numbers after species name) is clinically critical.

Postbiotics: The Next Frontier

The International Scientific Association for Probiotics and Prebiotics (ISAPP) formally defined 'postbiotics' in 2021 as bioactive compounds produced by food-grade microorganisms, including heat-killed bacteria, cell wall fragments, and metabolites. A review in Gut Microbes demonstrated that postbiotic preparations of Lactobacillus paracasei produced equivalent anti-inflammatory effects to live cultures, with superior shelf stability and safety profile.

Spore-Based Probiotics and Survival

Bacillus coagulans and B. subtilis form endospores that survive stomach acid, bile, and heat, arriving intact in the colon. A 2021 randomized trial in Probiotics and Antimicrobial Proteins showed that Bacillus coagulans MTCC 5856 significantly reduced IBS symptoms and improved stool consistency after 8 weeks. Spore formers do not require refrigeration, offering practical advantages over fragile Lactobacillus strains.

Saccharomyces boulardii (Probiotic Yeast)

Unlike bacterial probiotics, S. boulardii is a tropical yeast strain isolated from lychee fruit in 1923 by French scientist Henri Boulard. It is inherently resistant to antibiotics, making it the only probiotic proven effective when taken alongside antibiotic therapy. Clinical evidence supports its use for C. difficile infection prevention, traveler's diarrhea, and acute gastroenteritis in children. It does not colonize permanently.

Take S. boulardii 250-500mg twice daily during and for one week after antibiotic courses. Unlike bacterial probiotics, it is unaffected by antibiotics and can be taken simultaneously.

THIS WEEK IN BRIEF

► REGULATION: EFSA tightens health claim regulations for probiotic products in the EU, requiring strain-level identification and clinical trial evidence for any marketed benefit.

► MARKET: Global probiotic market reaches $61 billion, with strain-specific supplements and postbiotic products driving growth beyond traditional yogurt and kefir categories.

► INNOVATION: MIT engineers develop a 'smart probiotic' pill with pH-sensing coating that releases live bacteria only in the colon, achieving 100-fold higher colonization rates.

ORIM Tip: When choosing a probiotic supplement, look for the full strain designation (e.g., Lactobacillus rhamnosus GG, not just 'Lactobacillus'). Check that the product guarantees CFU count at expiration, not at manufacture, as viability drops significantly during shelf life.